Shababa T. Masoud

Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease

Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry et al. · Science Translational Medicine · 2022 · 230 citations

Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits

Shababa T. Masoud, Laura M. Vecchio, Yan Bergeron et al. · Neurobiology of Disease · 2014 · 150 citations · Full text

Neurophysiology, Dopamine Transporter, Physiology +11

Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia

Dan Xia, Steve Lianoglou, Thomas Sandmann et al. · Molecular Neurodegeneration · 2022 · 112 citations · Full text

Misassembly of full-length Disrupted-in-Schizophrenia 1 protein is linked to altered dopamine homeostasis and behavioral deficits

Svenja V. Trossbach, Verian Bader, Laura Hecher et al. · Molecular Psychiatry · 2016 · 89 citations · Full text

The cost-effectiveness of palivizumab for respiratory syncytial virus prophylaxis in premature infants with a gestational age of 32–35 weeks: a Canadian-based analysis

Krista L. Lanctôt, Shababa T. Masoud, Bosco Paes et al. · Current Medical Research and Opinion · 2008 · 73 citations